Long-Term Combined Training in Idiopathic Pulmonary Fibrosis: A Case Study

被引:7
|
作者
Naranjo-Orellana, Jose [1 ]
Santalla, Alfredo [1 ,2 ]
机构
[1] Pablo de Olavide Univ, Dept Sport & Comp, Seville 41013, Spain
[2] Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
关键词
inspiratory muscle training; resistance training; idiopathic pulmonary fibrosis; LUNG TRANSPLANTATION; INSPIRATORY MUSCLE; VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; REHABILITATION; BENEFITS; OUTCOMES;
D O I
10.3390/ijerph17145091
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A supervised combined training program was applied to a sedentary 56-year-old man with idiopathic pulmonary fibrosis (IPF) along three years, until lung transplantation. It included: (a) aerobic continuous (CT) and interval training (IT), (b) high load resistance training (RT) and (c) inspiratory muscle training (IMT). IT and IMT were applied for two years, while CT and RT could be maintained until transplantation using supplemental oxygen. Maximal inspiratory pressure (MIP) kept above 180 cm H2O and forced vital capacity (FVC) remained stable until lung transplantation. Peak oxygen uptake VO(2)increased during 1.5 years before its decline, staying above the poor prognosis level two years. Finally, the patient maintained his walking capacity and independence for 2 years, before the decline due to the disease. After receiving a two-lung transplant, the patient remained intubated for 12 h, left the intensive care unit after 3.5 days and was discharged after 18 days (average values: 48 h, 7-10 days and 25-35 days, respectively). These results show that systematic and supervised combined training can be safety applied in an IPF patient to maintain functionality and quality of life. In addition, we show that RT can be maintained for as long as necessary without complications.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [41] SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): LONG-TERM GLOBAL PHARMACOVIGILANCE DATA
    Lasky, Joseph
    Criner, Gerard
    Lazarus, Howard
    Kohlbrenner, Veronika
    Bender, Shaun
    Richeldi, Luca
    CHEST, 2019, 156 (04) : 1011A - 1012A
  • [42] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Tomos, Ioannis
    Dimakopoulou, Konstantina
    Manali, Effrosyni D.
    Papiris, Spyros A.
    Karakatsani, Anna
    ENVIRONMENTAL HEALTH, 2021, 20 (01)
  • [43] Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON
    Song, Jin Woo
    Ogura, Takashi
    Inoue, Yoshikazu
    Xu, Zuojun
    Quaresma, Manuel
    Stowasser, Susanne
    Stansen, Wibke
    Crestani, Bruno
    RESPIROLOGY, 2020, 25 (04) : 410 - 416
  • [44] Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
    Cottin, Vincent
    Maher, Toby
    EUROPEAN RESPIRATORY REVIEW, 2015, 24 (135): : 58 - 64
  • [45] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Ioannis Tomos
    Konstantina Dimakopoulou
    Effrosyni D. Manali
    Spyros A. Papiris
    Anna Karakatsani
    Environmental Health, 20
  • [46] Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry
    Sack, Coralynn
    Wojdyla, Daniel M.
    Macmurdo, Maeve G.
    Gassett, Amanda
    Kaufman, Joel D.
    Raghu, Ganesh
    Redlich, Carrie A.
    Li, Peide
    Olson, Amy L.
    Leonard, Thomas B.
    Todd, Jamie L.
    Neely, Megan L.
    Snyder, Laurie D.
    Gulati, Mridu
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2025, 22 (03) : 378 - 386
  • [47] Correction to: Risk of progression of idiopathic pulmonary fibrosis to connective tissue disease: a long-term observational study in 527 patients
    Byeongzu Ghang
    So Hye Nam
    Jungsun Lee
    Doo-Ho Lim
    Soo Min Ahn
    Ji Seokchan Hong
    Yong-Gil Kim
    Bin Yoo
    Jinseok Kim
    Chang-Keun Lee
    Clinical Rheumatology, 2021, 40 : 2525 - 2525
  • [48] Exercise training in idiopathic pulmonary fibrosis
    Vainshelboim, Baruch
    Fox, Benjamin Daniel
    Oliveira, Jose
    Kramer, Mordechai Reuven
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 69 - 77
  • [49] Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis
    Doi, Takehiko
    Ohga, Shouichi
    Ishimura, Masataka
    Takada, Hidetoshi
    Ishii, Kanako
    Ihara, Kenji
    Nagai, Hideyuki
    Hara, Toshiro
    EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (11) : 1475 - 1481
  • [50] Long-term outcome of idiopathic pulmonary hemosiderosis in children
    Le Clainche, L
    Le Bourgeois, M
    Fauroux, B
    Forenza, N
    Dommergues, JP
    Desbois, JC
    Bellon, G
    Derelle, J
    Dutau, G
    Marguet, C
    Pin, I
    Tillie-Leblond, I
    Scheinmann, P
    De Blic, J
    MEDICINE, 2000, 79 (05) : 318 - 326